Treatment with poly- and monoclonal antilymphocyte antibodies: assessment of efficacy and safety in transplantation.
Claesson
K
K
Department of Urology, University Hospital, Sweden.
Tufveson
G
G
Wahlberg
J
J
D000961:Antilymphocyte Serum / Q000009:adverse effects / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006084:Graft Rejection; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000009:adverse effects / Q000627:therapeutic use*; D012189:Retrospective Studies
D000961:Antilymphocyte Serum; D016853:Muromonab-CD3